STATE STREET CORP - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,480,660
-19.8%
3,065,967
+0.8%
0.00%0.0%
Q2 2023$25,521,256
+1383.2%
3,041,866
+1655.5%
0.00%
Q1 2023$1,720,680
-28.7%
173,281
-50.0%
0.00%
Q4 2022$2,412,072
+159.6%
346,562
+99.3%
0.00%
Q3 2022$929,000
+33.9%
173,8810.0%0.00%
Q2 2022$694,000
-82.2%
173,881
-80.2%
0.00%
Q1 2022$3,902,000
-68.4%
877,797
-71.5%
0.00%
-100.0%
Q4 2021$12,329,000
-59.0%
3,082,352
-10.1%
0.00%
-50.0%
Q3 2021$30,092,000
-15.2%
3,427,379
+9.4%
0.00%0.0%
Q2 2021$35,498,000
+23.3%
3,133,139
+29.3%
0.00%0.0%
Q1 2021$28,786,000
+20171.8%
2,423,024
+11605.4%
0.00%
Q4 2020$142,0000.0%20,700
+8.4%
0.00%
Q3 2020$142,000
+77.5%
19,1000.0%0.00%
Q2 2020$80,000
-92.0%
19,100
-95.3%
0.00%
Q1 2020$995,000
-59.0%
403,009
-3.4%
0.00%
Q4 2019$2,424,000
+15.3%
417,207
+4.6%
0.00%
Q3 2019$2,102,000
-12.2%
398,856
-0.1%
0.00%
Q2 2019$2,395,000
-25.3%
399,208
+12.4%
0.00%
Q1 2019$3,207,000
+35.8%
355,202
+24.9%
0.00%
Q4 2018$2,361,000
-30.7%
284,480
+15.3%
0.00%
Q3 2018$3,406,000
+81.1%
246,790
+4.3%
0.00%
Q2 2018$1,881,000
+869.6%
236,626
+812.5%
0.00%
Q1 2018$194,000
+25.2%
25,931
+14.4%
0.00%
Q4 2017$155,000
+16.5%
22,669
+22.5%
0.00%
Q3 2017$133,00018,5000.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 1,009,131$7,568,0001.15%
Knoll Capital Management, LLC 124,096$931,0000.96%
683 Capital Management, LLC 1,000,000$7,500,0000.66%
Perceptive Advisors 3,085,458$23,141,0000.65%
MANGROVE PARTNERS IM, LLC 324,019$2,430,0000.16%
Stanley-Laman Group, Ltd. 64,029$480,0000.11%
WOODSTOCK CORP 67,759$508,0000.10%
Hikari Power Ltd 107,858$809,0000.10%
ARDSLEY ADVISORY PARTNERS LP 45,000$336,0000.05%
ADAGE CAPITAL PARTNERS GP, L.L.C. 750,000$5,625,0000.01%
View complete list of ALDEYRA THERAPEUTICS INC shareholders